Preclinical and Clinical evaluation of the effect on oral administration of VAANI KIRUTHAM along with external application of VILVAPAZHA THYLUM with the procedure of SIRASU THAARAI in the management of ATTENTION DEFICIT HYPERACTIVITY DISORDER in paediatric age group
Phase 2
- Conditions
- Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
- Registration Number
- CTRI/2022/11/047018
- Lead Sponsor
- DR SUBBULAKSHMI S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.HYPERACTIVITY/IN ATTENTION/ IMPULSIVITY
2.CLINICALLY DIAGNOSED AS ADHD
3.POOR CONCENTRATION
4.TALKING NONSTOP
5.BLURTING THINGS OUT
6.FREQUENT JUMPING
7.TROUBLE IN SITTING
8.INABILITY TO REACT
9.ANGRY AND ARGUE WITH OTHERS
Exclusion Criteria
1.SEIZURE DISORDERS
2.CEREBRAL PALSY
3.AUTISTIC SPECTRUM DISORDER
4.POST TRAUMATIC HEAD INJURY
5.POST ENCHEPHALITIC DISORDER
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method